Hypera S.A.
HYPE3
Rangering i aksjer
#4209
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Aksjekurs
$5.32
Sist synkronisert: 2026-10-21
Markedsverdi
$3.74B
Endring (1 dag)
2.01%
Endring (1 år)
24.78%
Land
BR
Handel Hypera S.A. (HYPE3)
Kategori
Healthcare
Aksjeprishistorikk for Hypera S.A. (HYPE3)
Høyeste sluttskurs: $5.03 den 2026-10-01
Laveste sluttskurs: $4.81 den 2008-04-01
Laveste sluttskurs: $4.81 den 2008-04-01
Aksjeprishistorikk for Hypera S.A. fra 2008 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -0.69% |
| 2025 | 45.17% |
| 2024 | -58.10% |
| 2023 | -12.37% |
| 2022 | 62.46% |
| 2021 | -21.43% |
| 2020 | -22.43% |
| 2019 | 1.82% |
| 2018 | -25.66% |
| 2017 | 46.20% |
| 2016 | 28.75% |
| 2015 | -6.93% |
| 2014 | -19.33% |
| 2013 | 0.07% |
| 2012 | 62.59% |
| 2011 | -67.38% |
| 2010 | 28.81% |
| 2009 | 327.96% |
| 2008 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.53 | -3.54% |
IN
|
